Adults with attention-deficit/hyperactivity disorder (ADHD) consistently score lower on happiness and quality of life ...

A new study has found clear evidence of inappropriate prescribing of antipsychotic treatments to children and young people (CYP) and low levels of aftercare monitoring by GPs and also raises concerns ...

A new study has found clear evidence of inappropriate prescribing of antipsychotic treatments to children and young people (CYP) and low levels of ...

Nearly 300,000 people in the Netherlands received medication for ADHD in 2023, almost four times as many as in 2006, national ...

Mumbai: Mumbai-based pharma giant Cipla is gearing up to make an entry into India's rapidly growing weight management market, ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.

Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...

Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...